Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Member organizations and others share their perspectives on a wide variety of topics relating to public and private sector research and innovation, and public health. The views expressed by contributors are their own and not the view of Research!America.

Recent Blog Posts

The fall 2019 edition of Research!America's newsletter, the Research Advocate, is now online ! Among the articles in this issue: Advocacy Award Recipients Announced The 24th annual Research!America Advocacy Awards, to be held at the Andrew W. Mellon Auditorium in Washington, D.C. on March 11, 2020, brings together leaders from government, industry, academia, patient groups, scientific societies, independent research institutes, and health advocacy organizations to honor exceptional advocates for research. Earlier this month, Research!America announced the first round of recipients for many of the awards. Bruce M. Alberts, PhD , former president (1993-2005) of the National Academy of...
Dear Research Advocate, Today, we announced several of the extraordinary leaders in medical and health research advocacy who will be honored during our 2020 Advocacy Awards Dinner. Dr. Bruce Alberts, former president of the National Academy of Sciences (among a plethora of distinctions), will receive this year’s John Edward Porter Legacy Award, generously supported by Ann Lurie. Bruce is just one of the remarkable individuals who will be recognized, as highlighted in today’s release . We will soon announce the recipients of the Isadore Rosenfeld Award for Impact on Public Opinion and the Edwin C. Whitehead Award for Medical Research Advocacy . I hope you will join us on March 11, 2020, to...
In 2013, President Obama announced The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative , an ambitious ten-year plan tasked with “revolutionizing our understanding of the human brain.” The BRAIN Initiative seeks to expedite discoveries about the fundamental workings of the brain, so that researchers can better tackle the many diseases and disorders of this complex organ. The BRAIN Initiative spans several federal entities and includes partnerships with industry leaders, and academia, among others. In 2019, we are halfway through the Initiative’s time frame. At a recent briefing held by the Coalition for Life Sciences , guest speakers Dr. Eva Marder , PhD,...
Dear Research Advocate, Congress has five weeks to reach an agreement on full-year FY20 funding levels before the current stop-gap continuing resolution (CR) expires on November 21, 2019. House spending leaders sent their Senate counterparts new totals for the 12 annual appropriations bills, but word is, negotiations on those topline amounts are far from over and concerns are mounting that Congress could resort to another short-term CR. CRs are the enemy of medical and public health progress: consider the recent NIH-supported finding that the artificial pancreas system controls blood glucose levels better than current technology in patients with Type 1 diabetes or promising results in...
Dear Research Advocate, The distinguished 2019 Nobel Laureates announced this week made fundamental discoveries that have transformed the future for Americans and populations across the globe. Taxpayers, via appropriations to NIH and NSF, have long provided support to several of these and many past Nobelists, thereby ensuring that discovery builds on discovery and drives development and delivery of ever-increasing societal benefits over time. (See our statements here and here ) But what are we doing to nurture future Nobel laureates? Robust NIH and NSF support for researchers across the nation hinges on the ability of the House and Senate to negotiate final FY20 appropriations before the...
“Many or most public health issues are inherently local, but the federal government still has an important role to play, and they have resources to bare when needed,” said Chrissie Juliano , Executive Director of the Big Cities Health Coalition (BCHC) . On September 23, 2019, the BCHC and the American Academy of Pediatrics (AAP) , a Research!America member, addressed this topic in a briefing titled “The Measles Outbreaks of 2018/2019: Perspectives from Local Communities.” At this event, along with Ms. Juliano, spoke Dr. Colleen Kraft , Immediate Past President of AAP; Dr. Oxiris Barbot , Commissioner of the New York City Department of Health and Mental Hygiene; and Dr. Jeffrey Gunzenhauser...
Dear Research Advocate, As part of the U.S. Chamber of Commerce’s launch of Civics Forward , CEO Thomas Donahue challenged the business community to play a leading role in civic education, for no less a reason than assuring the future of our nation. This challenge is reminiscent of his call to the science community last February at the AAAS meeting to do more with the business community, in order to achieve shared aspirations. As he said at the time, “without science there is no innovation, and without innovation, there is no industry,” going on to emphasize the enduring value the business community accords to science. There is no question that heightened attention to civic education and...
Age-related Macular Degeneration (AMD) is a slow progression of blindness that affects 10 million Americans. It starts with slightly fuzzy vision, and continually worsens until the center of vision is so blurred the patient can no longer recognize faces, read, drive, or perform many other daily activities. At a recent briefing held by Research!America alliance member the National Alliance for Eye and Vision Research (NAEVR), ­patient activist Sydney Ruth Torrey of the American Macular Degeneration Foundation described the progression of AMD as “first annoying, then maddening, and finally devastating.” She expressed the heartbreak of Americans with AMD who find one day that their vision has...
Dear Research Advocate, Earlier today, the Senate passed legislation, known as a Continuing Resolution or “CR,” extending government funding to midnight November 21, 2019. The President is expected to sign the legislation before the end of Fiscal Year 2019, September 30. That means Congress has seven-plus additional weeks to reach an agreement. The problem is that CRs stall progress, and one CR is more than enough! We are launching a campaign to urge Congress to reach a bipartisan agreement by or before November 21st that will ensure robust scientific, health, and medical research funding for all of Fiscal Year 2020. Visit our action page and send an email and/or Tweet to make the case for...
Dear Research Advocate, This week was chock-full of federal appropriations activity bearing on the future of research, and ultimately, the future of health. While agency funding for Fiscal Year 2020 is far from resolved, some very positive and not-so-positive steps were taken by Congress. First, the Senate Appropriations Committee released its long-awaited Labor/HHS bill. The exciting headline is that NIH received a vital $3 billion increase, which, if enacted, would bring its total funding to $42.08 billion. The CDC, meanwhile, would receive an increase of only $180 million for a total budget of $7.46 billion. This increase is woefully insufficient to enable CDC’s 24/7 vigilance and...

Pages

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter